Karl Heideck: Influential Pennsylvania Attorney

Attorney Karl Heideck as given his personal approval to the new and improved car seat law in Pennsylvania. Since vehicle accidents are one of the top leading causes of death for infants and small children, their safety was a top priority for the state and Heideck. Basically, the new law states that children under the age of 2 must be in a rear facing care seat and children under 80 pounds must be in a booster seat. The fines can range from 75 to 125 dollars. Karl Heideck encourages all parents to review the new standards and make sure they are following the new laws set in place by the state. Ways to ensure your child’s safety are to check with care seat manufacturers for recalls, never buy used car seats, and visit one to the state’s many care seat safety inspection sites for more information. The Insurance Institute of Highway Safety also issues a list of the safest car seats every year. Parents can also register their car seat that they have purchased with the manufacturer so that they are notified if there is ever a recall on their specific car seat model. Pennsylvania was the 4th state to pass these stricter care seat regulations. And Karl Heideck was one of many lawmakers in the state to push for the new law to pass. Traffic, government, and legal experts hope that other states will follow Pennsylvania’s example when it comes to care safety for babies and children.

Karl Heideck completed his law degree at Temple University Beasley School of Law. He received his bachelor’s degree in 2003 from Swarthmore College. Heiddeck’s major was English. His area of focus are intellectual property law, civil litigation, employment law, commercial litigation, corporate law and legal research. He has practiced law in Philadelphia for over 10 years. He enjoys writing about legal issues that are affecting the state. He has clients not only in Pennsylvania but across the United States. He is a respected lawyer and valued opinion writer for the local legal community. He is also active on social media sites like Facebook and Twitter.

To know more visit @: www.martindale.com/Karl-Heideck/168775858-lawyer.htm

Dr. Clay Seagall’s Vital Contribution Towards the Biopharmaceutical Industry

Seattle Genetics is a biotechnical company that is dedicated to inventing more efficient, less invasive ways of treating cancer. It also goes without saying that they are too broad in researching on effective antibody-based therapies that will not only help quell the devastating symptoms of cancer, the equally adverse side effects of chemotherapy naturally but also prolong life.

Some of these antibody therapies that are under clinical trials at Seattle Genetics include Breast Cancer Therapies, Hodgkin Lymphoma Therapy, Urothelial Cancer as well as Non-Hodgkin Lymphoma Therapies. And needless to say, the experts are very confident with the strides they have been taking of late, hinting that a breakthrough might be realized shortly.

Quite a number of the careers that have so far been promoted by Seattle Genetics and so far, they have well over a thousand employees under their umbrella. Dr. Clay Siegel has also made sure that he is doing all in his power to get everything that the staff needs to take good care of their patients. And apart from being the brilliant doctor that he is, Clay Seagall is also the president, CEO of Seattle Genetics.

Before Dr. Seagall because co-founding and heading of Seattle Genetics in 1998, he had to go to school and acquire all of the necessary experience that officially put him on the map as the legitimate candidate. He began his journey after acquiring a Bachelor of Science Degree from the University of Maryland and later successfully added at Ph.D. in Genetics acquired from George Washington University to his already impressive credentials.

After school, Dr. Clay Seagall had to join other medical firms to not only practice but to also gain the much-needed experience to start his practice. He worked as the director of Alder Biopharmaceuticals and Mirna Therapeutics – the two privately owned biopharmaceutical companies that are currently doing well under his leadership.

Between 1991 and 1997, Dr. Clay Seagall worked as a pharmacist at Bristo-Myers Squibb Pharmaceutical Research Institute, which also contributed a great deal to his experience in the business.

That goes to show that apart from being a brilliant, highly-qualified doctor, Clay Seagall also happens to be an experienced entrepreneur and a leader, especially in the biopharmaceutical industry. Even after spending a lot of years in the biopharmaceutical industry and achieving so much, it seems as though only the sky is the limit for the good doctor since he is showing no signs of stoppingg.